Related by context. Frequent words. (Click for all words.) 72 Patient Enrollment 71 Preclinical Data 70 Patent Covering 70 Drug Candidate 70 FDA Accepts 69 Clinical Trial Results 69 Announces Publication 68 Phase III Trial 68 Completes Enrollment 68 Announces Initiation 68 Phase III Clinical Trial 67 Mechel Announces 67 Successful Completion 67 Provides Guidance 67 Small Molecule 66 Generic Version 66 Option Grants 66 RNAi Therapeutics 66 Presents Positive 66 FDA Clearance 66 Announces Issuance 65 Private Placement Financing 65 Receives Patent 65 Initiates Phase 65 Previously Announced 65 FDA Clears 65 Metastatic Melanoma 65 Vertex Pharmaceuticals Announces 65 Closes Financing 65 Pivotal Phase III 64 Explore Strategic Alternatives 64 Pivotal Phase 64 Annual Meeting Date 64 Smallpox Vaccine 64 Shelf Registration Statement 64 Metastatic Colorectal Cancer 64 Prostate Cancer Patients 64 Well Tolerated 64 Study Demonstrates 64 FDA Orphan Drug 64 Record Third Quarter 63 Updates Shareholders 63 Completes Private Placement 63 Pivotal Trial 63 Patent Infringement Lawsuit 63 Positive Opinion 63 Updates Guidance 63 Complete Merger 63 Achieves Milestone 63 Regains Compliance 63 Malaria Vaccine 63 Director Shareholding 63 Completes Tender Offer 63 Elderly Patients 63 Guidance Quick Facts 63 Share Repurchases 63 Receives Regulatory 63 Announces Presentation 63 Significant Increase 63 Regains Compliance With 62 Significantly Reduces 62 Record Second Quarter 62 Updates Status 62 Patent Issued 62 Chronic Hepatitis C 62 Issues Guidance 62 Low Dose 62 Receives Positive 62 Announces Shareholder Approval 62 Exclusive License 62 Cervical Cancer Vaccine 62 FY# Guidance 62 Announces Successful Completion 62 Reports Positive 62 Announces Receipt 62 Gastric Cancer 62 Privately Held 62 Q3 Loss Widens 62 Anthrax Vaccine 62 Sixth Consecutive Year 62 Final Tranche 62 Private Placement Offering 62 Cholesterol Drug 62 Cash Tender Offers 62 Closes Private Placement 62 Announces Filing 62 Fifth Consecutive Year 62 Provides Updates 61 Q2 Loss Narrows 61 Common Share Dividend 61 Announces Termination 61 Receives Notice 61 Grants Options 61 Subsidiary Receives 61 Shareholder Letter 61 Eaton Vance Closed End 61 Q2 Loss Widens 61 Announces Commencement 61 Reduces Risk 61 Q1 Loss Narrows 61 Adroit Resources Inc.